Search

everythinglearnresearchcommunity

for

Search:↓

A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.

The growth factor cocktail with FGF9 significantly increased hair density and diameter in patients with androgenetic alopecia.

Combining PRP with micro-needling improves hair growth and thickness in treating hair loss.

Changes in NRF2 levels may contribute to hair loss in Egyptian men.

The treatment increased hair growth and thickness in patients with hair loss.

Combining laser light therapy and growth factor treatment improves hair growth in people with hair loss.

A 0.5 mm microneedle depth is more effective for increasing hair density in treating hair loss.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Laser therapy and hair growth factors significantly improve hair density in male baldness.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Both genetics and lifestyle factors contribute to male pattern baldness.

Higher energy, longer exposure, and pulse irradiation improve hair density in androgenetic alopecia treatment.

Targeting specific genes in certain pathways may help treat male pattern baldness.

CGF from platelets helps hair regrowth in people with androgenetic alopecia.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

Combining PRP with CGF is more effective for hair regrowth in androgenetic alopecia than PRP alone.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Using growth factor injections and minoxidil together can significantly improve hair growth in people with hair loss.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Concentrated growth factors may help treat hair loss caused by genetics.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Balding hair follicles have reduced growth factors and increased inhibitory factors, suggesting new treatment paths for hair loss.

Using a special laser and growth serum can safely increase hair thickness and density in people with hair loss.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

The rs6152 allele is not a good marker for baldness in the Indonesian population, but family history, age, gender, high blood pressure, and body weight are linked to the risk.

Hair loss linked to higher heart disease risk in both men and women.